Navigating the recent growth in asthma medications The National Asthma Council Australia has launched new resources to help inform health professions about treatment options.
Semaglutide shortage prompts caution around off-label prescribing GPs are being asked to prioritise the drug for people with diabetes, but with supplies critically low, what are the alternatives?
Concern over significant NPS MedicineWise changes The recent budget revealed a ‘redesign’ for stewarding the quality use of medicines, with major implications for the organisation.
Thousands expected to benefit from new PBS listings Medications for asthma, HIV, and Crohn’s disease have been added, while some heart, cholesterol and blood pressure drugs are now cheaper.
NPS MedicineWise partnership to strengthen the role of GPs The collaboration builds on a shared goal of improving quality use of medicines, clinical decision making and general practice education.
Which medicines could be in short supply in 2022? The pandemic has proven time and time again that it is a potent driver of shortages – but the end of COVID-induced medicine supply issues may come sooner than expected.
Taking the burden out of anticholinergic medicines A new program targeting the use of anticholinergic medicines has been launched by NPS MedicineWise.
What medicines are prescribed the most in Australia? While statin medications take the lion’s share, antidepressants are being prescribed more, and antibiotics less.
National Medicines Policy submission focuses on clinical practice Key recommendations for the policy’s review put forward by the RACGP are aimed at ensuring access, safety and quality.
In Practice: What are the latest college submissions? GPs and GPs in training can also learn more about current rural health topics and apply for educational committees.